• I managed Norditropin products covering strategic and tactical planning. • I developed and implemented the Awareness Campaign together with the Creciendo Patient Association (@asoc.creciendo) achieving a significant increase in followers and amplification of the message by combining both the digital campaign and the face-to-face activities.• I achieved a significant increase in early referral by non-visited general practitioners to specialists, using a comprehensive digital ecosystem combined with face-to-face activities.• I developed and implemented the dissemination of new promotional messages combining an optimal balance between face-to-face and digital channels.• I managed the budget of the brand without deviations. I improved the accuracy of the sales forecast.• I led the pricing strategy with a focus on maximizing profitability.• I promoted and amplified the services of the Patient Program with a focus on education.• I managed to expand and consolidate solid relationships with Key Opinion Leaders (KOLs) and Scientific Societies.• I successfully supervised the alignment of my team with the Company Compliance Policies.

• I managed the Aimovig product covering its strategic and tactical planning.• I developed and implemented the 100% Digital Ecosystem "Espacio Migraña" integrating Web, App & bidirectional social networks, achieving an end-to-end Patient Journey including the "find your specialist" function.• I managed the e-commerce channel for migraine with national reach (Pricing Strategy 100% out of pocket).• I developed and implemented the dissemination of new promotional messages combining an optimal balance between face-to-face and digital channels.• I led the launch of new presentations reaching a better penetration of the product.• I managed the budget of the brand without deviations and improved the accuracy of the sales forecast.• I led the pricing strategy with a focus on maximizing profitability.• I promoted and amplified the services of the Patient Program with a focus on education.• I managed to expand and consolidate solid relationships with KOLs and Scientific Societies.• I successfully supervised the alignment of my team with the Company Compliance Policies.

• I managed the Galvus, Diovan & Exforge products covering their strategic and tactical planning.• I carried out the strategic analysis of the cardio metabolism market for the BD&L area and new businesses.• I developed and implemented the dissemination of new promotional messages combining an optimal balance between face-to-face and digital channels.• I managed the budget of the brand without deviations. I improved the accuracy of the sales forecast.• I led the pricing strategy with a focus on maximizing profitability.• I enhanced and amplified the services of the Patient Program with a focus on product accessibility.• I managed to expand and consolidate solid relationships with KOLs and Scientific Societies.• I successfully supervised the alignment of my team with the Company Compliance Policies.

• I represented and succesfully managed to position the product "Entresto" as part of the mindset of physicians.• I managed to generate and consolidate solid long-term relationships with Physicians, KOLs, Institutions, Drugstores, Pharmacies and Health Medical Organizations in my area.• I generated access for the product in Health Medical Organizations and Payers with a focus on pricing and joint venture agreements.• I developed and consolidated new key accounts for the area.• I provided product access support with a focus on process agility.• I organized continuous medical education activities between Institutions and health professionals.• I optimized my own effectiveness through proper planning of activities, targeting, customer segmentation and compliance with metrics.• I exceeded the objectives established for the brand with a clear focus on increasing market share.

• I managed and negotiated the following expenses categories for Novartis, Sandoz and Alcon: Warehouse and Distribution, Fleet and Clinical Studies, having also managed Real Estate, IT and Laboratory Services.• I carried out the coordination and leverage between the 3 companies of the Group (Sandoz, Novartis and Alcon).• I performed the role of Business Partner for Alcon focused on cost reduction and best practices seeking synergy among the group's internal clients by managing and following the Compliance Policies.• I conducted electronic auctions.• Annual volume managed: USD M$13. Annual saving 7.5%.

• I managed and negotiated the following categories of expenses: Logistics, Fleet, IT, Real State, Congresses, and Events. Focused on cost reduction and best practices seeking synergy among internal customers.• I carried out the planning and elaboration of strategic purchase plans in the short and medium term.• I led the performance management of strategic suppliers including implementation of SLAs, by managing and following the Compliance Policies.• Annual volume managed: USD M$6. Annual saving 7%.

Agrega S.A. Agrega is a company created by Cervecería y Maltería Quilmes and Nobleza Piccardo with the aim of optimizing its purchases of services and indirect materials.• I managed and negotiated the following categories: Capex, Corporate Spend, Logistics Services, Financial Services and Environment for both companies.• I carried out the planification, coordination, and analysis of sourcings with national and regional scope focused on cost reduction and best practices seeking synergy between internal clients.• I performed the evaluation of local and regional market trends. I designed the performance reports and monitored the indicators. I carried out electronic auctions (Traditional and Reverse).• I carried out the budget control and monitored of the forecast following the Compliance policies.• Annual volume managed: USD M$8. Annual saving 12%

• I participated in the preparation of the annual internal audit program, and in the preparation of the compliance report covering the survey of internal processes and evaluation of the control system with a risk-based approach.• I participated in the operational and special audits including the preparation of the audit report with recommendations for improvement, follow-up and implementation of the observations.